| Title | Authors / Editors | Date |
unige:7558 |
A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study |
Rutschmann, Olivier Thierry; Opravil, M.; Iten, A.; Malinverni, R.; ... Hirschel, Bernard |
1998 |
unige:7105 |
Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study |
Bernasconi, Enos; Boubaker, Karim; Junghans, Cornelia; Flepp, Markus; ... Telenti, Amalio |
2002 |
unige:9447 |
Adding saquinavir to stavudine in patients with advanced HIV-1 infection |
Rutschmann, Olivier Thierry; Kaiser, Laurent; Perrin, Luc; Fathi, Marc; Hirschel, Bernard |
1997 |
unige:7106 |
Antiretroviral prophylaxis for community exposure to the human immunodeficiency virus in Switzerland, 1997-2000 |
Bernasconi, Enos; Jost, J.; Ledergerber, Bruno; Hirschel, Bernard; ... Sudre, Philippe |
2001 |
unige:9347 |
Antivirale Substanzen: Gegen was? Fur wen? |
Hirschel, Bernard |
1990 |
unige:7321 |
Beware of drug holidays before HIV salvage therapy |
Hirschel, Bernard |
2003 |
unige:7371 |
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy |
Kaufmann, G. R.; Furrer, Hansjakob; Ledergerber, Bruno; Perrin, Luc; ... Battegay, Manuel |
2005 |
unige:7466 |
Combination therapy in primary HIV infection |
Perrin, Luc; Hirschel, Bernard |
1996 |
unige:7096 |
Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients |
Battegay, M.; Vernazza, P. L.; Bernasconi, Enos; Flepp, Markus; ... Hirschel, Bernard |
2001 |
unige:7276 |
Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study |
Glass, T. R.; De Geest, Sabina; Weber, Rainer; Vernazza, P. L.; ... Bucher, H. C. |
2006 |
unige:7355 |
Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study Group |
Joly, V.; Moroni, M.; Concia, Ercole; Lazzarin, A.; ... de Cian, W. |
2000 |
unige:9448 |
Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study |
Rutschmann, Olivier Thierry; Opravil, M.; Iten, A.; Malinverni, R.; ... Hirschel, Bernard |
1998 |
unige:7242 |
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study |
Furrer, Hansjakob; Egger, M.; Opravil, M.; Bernasconi, Enos; ... Malinverni, R. |
1999 |
unige:7083 |
Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: the HIV Netherlands Australia Thailand Research Collaboration 001.4 study |
Ananworanich, Jintanat; Siangphoe, Umaporn; Hill, Andrew; Cardiello, Peter; ... Ruxrungtham, Kiat |
2005 |
unige:7173 |
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study |
Egger, M.; Hirschel, Bernard; Francioli, Patrick; Sudre, Philippe; ... Battegay, M. |
1997 |
unige:9287 |
Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007 |
Ballif, Marie; Ledergerber, Bruno; Battegay, Manuel; Cavassini, Matthias; ... Weber, Rainer |
2009 |
unige:7574 |
Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures |
Scherrer, A. U.; von Wyl, Viktor; Fux, C. A.; Opravil, Milos; ... Gunthard, Huldrych |
2010 |
unige:7328 |
Is it smart to continue to study treatment interruptions? |
Hirschel, Bernard; Flanigan, Timothy |
2009 |
unige:7317 |
Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection |
Hirsch, M. S.; Steigbigel, R. T.; Staszewski, Scholomo; McMahon, Deborah; ... Leavitt, R. Y. |
2003 |
unige:7559 |
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study |
Rutschmann, Olivier Thierry; Vernazza, P. L.; Bucher, H. C.; Opravil, M.; ... Hirschel, Bernard |
2000 |